Your browser doesn't support javascript.
loading
Cyclic hexadepsipeptides from the fermentation of Fusarium sp. DCJ-A and their cytotoxic activities.
Yang, Jia-Mei; Liao, Yong-Jian; Chen, Ning; Huang, Lei; Zhang, Li-Zhi; Du, Gang; Zhou, Min.
Afiliação
  • Yang JM; Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming 650031, China.
  • Liao YJ; School of Ethnic Medicine, Yunnan Minzu University, Kunming 650031, China.
  • Chen N; School of Ethnic Medicine, Yunnan Minzu University, Kunming 650031, China.
  • Huang L; School of Ethnic Medicine, Yunnan Minzu University, Kunming 650031, China.
  • Zhang LZ; School of Ethnic Medicine, Yunnan Minzu University, Kunming 650031, China.
  • Du G; School of Ethnic Medicine, Yunnan Minzu University, Kunming 650031, China.
  • Zhou M; Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming 650031, China.
J Asian Nat Prod Res ; 25(5): 503-509, 2023 May.
Article em En | MEDLINE | ID: mdl-35912898
ABSTRACT
Beauvercin H (1), a new cyclic hexadepsipeptide, and two known ones (2 and 3) were isolated from the EtOH extract of the solid culture of Fusarium sp. Their structures were elucidated by spectroscopic analysis, including extensive 1D and 2D NMR techniques, as well as comparison with literature values. Additionally, compounds 1-3 were tested for their cytotoxic activities. The results showed that all isolated compounds exhibited cytotoxic activities against five human cancer cell lines with IC50 values ranging from 1.379 to 13.12 µM.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fusarium / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fusarium / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article